References
- Stam RW, den Boer ML, Meijerink JP, . Differential mRNA expression of Ara-C-metabolizing enzymes explains Ara-C sensitivity in MLL gene-rearranged infant acute lymphoblastic leukemia. Blood 2003;101:1270–1276.
- Postel EH, Zou X, Notterman DA, . Double knockout Nme1/Nme2 mouse model suggests a critical role for NDP kinases in erythroid development. Mol Cell Biochem 2009;329:45–50.
- Mahlknecht U, Dransfeld CL, Bulut N, . SNP analyses in cytarabine metabolizing enzymes in AML patients and their impact on treatment response and patient survival: identification of CDA SNP C-451T as an independent prognostic parameter for survival. Leukemia 2009;23:1929–1932.
- Schaich M, Ritter M, Illmer T, . Mutations in ras proto-oncogenes are associated with lower mdr1 gene expression in adult acute myeloid leukaemia. Br J Haematol 2001;112:300–307.
- Rubin EH, Andersen JW, Berg DT, . Risk factors for high-dose cytarabine neurotoxicity: an analysis of a cancer and leukemia group B trial in patients with acute myeloid leukemia. J Clin Oncol 1992; 10:948–953.
- Yokoyama A, Okabe-Kado J, Wakimoto N, . Evaluation by multivariate analysis of the differentiation inhibitory factor nm23 as a prognostic factor in acute myelogenous leukemia and application to other hematologic malignancies. Blood 1998;91:1845–1851.
- Qu S, Long J, Cai Q, . Genetic polymorphisms of metastasis suppressor gene NME1 and breast cancer survival. Clin Cancer Res 2008;14:4787–4793.
- Ouatas T, Clare SE, Hartsough MT, . MMTV-associated transcription factor binding sites increase nm23-H1 metastasis suppressor gene expression in human breast carcinoma cell lines. Clin Exp Metastasis 2002;19:35–42.
- Stentoft J. The toxicity of cytarabine. Drug Saf 1990;5:7–27.
- Geller HM, Cheng KY, Goldsmith NK, . Oxidative stress mediates neuronal DNA damage and apoptosis in response to cytosine arabinoside. J Neurochem 2001;78:265–275.
- Koros C, Papalexi E, Anastasopoulos D, . Effects of AraC treatment on motor coordination and cerebellar cytoarchitecture in the adult rat. A possible protective role of NAC. Neurotoxicology 2007;28:83–92.
- Koros C, Kitraki E. Neurofilament isoform alterations in the rat cerebellum following cytosine arabinoside administration. Toxicol Lett 2009;189:215–218.
- Verstappen CC, Heimans JJ, Hoekman K, . Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management. Drugs 2003;63:1549–1563.
- Chaudhary UB, Haldas JR. Long-term complications of chemotherapy for germ cell tumours. Drugs 2003;63:1565–1577.
- Gottlieb D, Bradstock K, Koutts J, . The neurotoxicity of high-dose cytosine arabinoside is age-related. Cancer 1987;60:1439–1441.
- Schaich M, Rollig C, Soucek S, . Cytarabine dose of 36 g/m(2) compared with 12 g/m(2) within first consolidation in acute myeloid leukemia: results of patients enrolled onto the prospective randomized AML96 study. J Clin Oncol 2011;29:2696–2702.